A Phase 1/2 Randomized Study to Evaluate the Safety Tolerability Immunogenicity And Immunopersistence of a Clostridioides Difficile Vaccine Administered in a 2-Dose Regimen with Novel Adjuvants in Healthy Adults



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.